U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
DALTEPARIN
S79O08V79F
US Approved Rx (1994)
First approved in 1994
General
Record Details
Names
5
Classification
7
Identifiers
11
Display Structure
Relationships
3
Active Moiety
1
Modifications
1
Characteristic Attributes
4
DALTEPARIN
S79O08V79F
US Approved Rx (1994)
First approved in 1994
General
Approval Year
1994
152
Record Details
Substance Class
Polymer
Record UNII
S79O08V79F
Record Status
Validated (UNII)
Record Version
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
DALTEPARIN
Common Name
English
B01AB04
Preferred Name
English
.ALPHA.-HEPARIN
Common Name
English
DALTEPARIN [VANDF]
Common Name
English
Dalteparin [WHO-DD]
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Classification
7
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Heparin group
VATC
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Heparin group
dalteparin
WHO-VATC
QB01AB04
Anticoagulant Agent
Pharmacologic Substance
[C1909]
Agent Affecting Blood or Body Fluid
[C78275]
Anticoagulant Agent
[C263]
Low Molecular Weight Heparin
NCI_THESAURUS
C2578
Anticoagulant
LiverTox
Hematologic
Anticoagulant
LMW Heparin
LIVERTOX
261
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Anti-coagulant
[EPC]
NDF-RT
N0000175980
Heparin
Chemical Ingredients
[Chemical/Ingredient]
Carbohydrates
[Chemical/Ingredient]
Polysaccharides
[Chemical/Ingredient]
Glycosaminoglycans
[Chemical/Ingredient]
Heparin
[Chemical/Ingredient]
Heparin, Low-Molecular-Weight
[Chemical/Ingredient]
NDF-RT
N0000007961
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
IUPHAR
6803
PRIMARY
LACTMED
Dalteparin
PRIMARY
DAILYMED
S79O08V79F
PRIMARY
RXCUI
67109
PRIMARY
RxNorm
NCI_THESAURUS
C1453
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Display Structure
Export Data
Relationships
3
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
NZN256ZSV8
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
Amount:
12M44VTJ7B
DALTEPARIN SODIUM
SALT/SOLVATE -> PARENT
Amount:
E1U4X64NFM
TISSUE FACTOR PATHWAY INHIBITOR
TARGET -> INHIBITOR
Amount:
Showing 1 to 3 of 3 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
S79O08V79F
DALTEPARIN
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Modifications
1
Agent Modifications
Show
5
20
100
All
entries
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
FORMATION OF LOW MW HEPARIN
HYDROLYSIS AND OXIDATION
NITROUS ACID
T2I5UM75DN
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
4
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
ANTI XA ACTIVITY
ENZYMATIC
INHIBITION PER MG 160 IU/MG (average) [110 to 210] (limits)
ANTI IIA
ENZYMATIC
INHIBITION PER MG 60 IU/MG (average)
DEGREE OF SULFATION
PHYSICAL
PER DISACCHARIDE 2.2 (average)
MOL_WEIGHT:WEIGHT AVERAGE
CHEMICAL
WEIGHT AVERAGE 6000 Da (average) [5600 to 6400] (limits)
Showing 1 to 4 of 4 entries
Previous
1
Next
